- Home
- SNT vs TELA Comparison
SNT vs TELA Comparison
Compare SNT & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNT
- TELA
- Stock Information
- Founded
- SNT 1965
- TELA 2012
- Country
- SNT Canada
- TELA United States
- Employees
- SNT N/A
- TELA N/A
- Industry
- SNT Telecommunications Equipment
- TELA Medical/Dental Instruments
- Sector
- SNT Telecommunications
- TELA Health Care
- Exchange
- SNT Nasdaq
- TELA Nasdaq
- Market Cap
- SNT 95.2M
- TELA 80.7M
- IPO Year
- SNT 1993
- TELA 2019
- Fundamental
- Price
- SNT $4.44
- TELA $1.92
- Analyst Decision
- SNT
- TELA Strong Buy
- Analyst Count
- SNT 0
- TELA 4
- Target Price
- SNT N/A
- TELA $6.00
- AVG Volume (30 Days)
- SNT 66.9K
- TELA 58.2K
- Earning Date
- SNT 08-25-2025
- TELA 08-11-2025
- Dividend Yield
- SNT N/A
- TELA N/A
- EPS Growth
- SNT N/A
- TELA N/A
- EPS
- SNT 0.18
- TELA N/A
- Revenue
- SNT $36,690,000.00
- TELA $71,217,000.00
- Revenue This Year
- SNT N/A
- TELA $26.67
- Revenue Next Year
- SNT N/A
- TELA $22.63
- P/E Ratio
- SNT $24.67
- TELA N/A
- Revenue Growth
- SNT 8.36
- TELA 12.78
- 52 Week Low
- SNT $1.40
- TELA $0.86
- 52 Week High
- SNT $5.04
- TELA $4.70
- Technical
- Relative Strength Index (RSI)
- SNT 48.89
- TELA 51.12
- Support Level
- SNT $4.27
- TELA $1.60
- Resistance Level
- SNT $4.70
- TELA $2.19
- Average True Range (ATR)
- SNT 0.26
- TELA 0.18
- MACD
- SNT -0.06
- TELA -0.03
- Stochastic Oscillator
- SNT 30.43
- TELA 53.49
About SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.